SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS RISPERIDONA INYECTABLE, RILPIVIRINA...
1 supplier awarded•31 lots awarded•€37.54M awarded
Buyer: Servicio Murciano de Salud / Espinardo, Spain
Awarded value
€37.54M
Estimated value
€206.14M
Awarded at 18% of estimated value
Award date
Mar 20, 2024
Winners
1
Lots awarded
31
Award values
Notice total
€37.54M
Sum of lot awards
€45.93M
TED notice total and lot-level values do not exactly match.
Winners
Pozuelo de Alarcón, ESP
€37.5M This contract
22 award notices•86 awarded lots•€189.05M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0031 | JANSSEN-CILAG, S.A. | €8.6M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0012 | JANSSEN-CILAG, S.A. | €6.4M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0003 | Not specified | €5.4M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0007 | JANSSEN-CILAG, S.A. | €5.0M | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0013 | JANSSEN-CILAG, S.A. | €2.8M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0022 | JANSSEN-CILAG, S.A. | €2.7M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0005 | Not specified | €2.7M | Other nervous system medicinal products (33661700) | |
| LOT-0025 | JANSSEN-CILAG, S.A. | €2.6M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0030 | JANSSEN-CILAG, S.A. | €1.5M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0020 | JANSSEN-CILAG, S.A. | €1.2M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0011 | JANSSEN-CILAG, S.A. | €1.1M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0006 | JANSSEN-CILAG, S.A. | €1.0M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0019 | JANSSEN-CILAG, S.A. | €732,132 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0021 | JANSSEN-CILAG, S.A. | €650,784 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0024 | JANSSEN-CILAG, S.A. | €592,740 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0008 | JANSSEN-CILAG, S.A. | €523,990 | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0028 | JANSSEN-CILAG, S.A. | €381,640 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0023 | JANSSEN-CILAG, S.A. | €366,656 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0027 | JANSSEN-CILAG, S.A. | €352,880 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0018 | JANSSEN-CILAG, S.A. | €271,160 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0001 | Not specified | €216,757 | Antineoplastic and immunomodulating agents (33652000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0016 | JANSSEN-CILAG, S.A. | €135,580 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0017 | JANSSEN-CILAG, S.A. | €122,253 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0010 | JANSSEN-CILAG, S.A. | €106,926 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0029 | JANSSEN-CILAG, S.A. | €95,740 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0015 | JANSSEN-CILAG, S.A. | €53,331 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0009 | JANSSEN-CILAG, S.A. | €52,399 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0004 | JANSSEN-CILAG, S.A. | €41,684 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0014 | JANSSEN-CILAG, S.A. | €32,913 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0026 | JANSSEN-CILAG, S.A. | €17,644 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0033 | Not specified | — | Psycholeptics (33661500) |